Skip to main content
. 2022 Aug 19;101(33):e30079. doi: 10.1097/MD.0000000000030079

Table 1.

The NMBM of PD research of top 10 countries/regions.

Ranking Country/region Frequency Centrality
1 USA 137 0.46
2 UK 40 0.19
3 China 39 0.02
4 Canada 38 0.09
5 Germany 37 0.17
6 Italy 32 0.07
7 Spain 23 0.15
8 Netherlands 16 0.05
9 Australia 14 0.27
10 South Korea 14 0.00

China = the People’s Republic of China, NMBM = neuroimaging biomarker, PD = Parkinson disease, UK = The United Kingdom of Great Britain and Northern Ireland, USA = United States of America.